Drug Shortage Report for JAMP-LOSARTAN
Report ID | 218703 |
Drug Identification Number | 02398834 |
Brand name | JAMP-LOSARTAN |
Common or Proper name | Losartan Potassium Tablets |
Company Name | JAMP PHARMA CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | LOSARTAN POTASSIUM |
Strength(s) | 25MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 3x10 |
ATC code | C09CA |
ATC description | ANGIOTENSIN II ANTAGONISTS, PLAIN |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2024-02-05 |
Estimated end date | 2024-07-31 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-02-07 |
Company comments | Bottle 100 available |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2024-02-07 | French | Compare |
v1 | 2024-02-07 | English | Compare |
Showing 1 to 2 of 2